Sign in

Jay Richards

Chief Risk Officer of BankUnited, N.A. at BankUnitedBankUnited
Executive

About Jay Richards

Jay D. Richards is Chief Risk Officer (CRO) of BankUnited, N.A., a role he has held since September 2019; he previously served as Chief Credit Officer from January 2018 to September 2019. He has a B.S. in Finance from Indiana State University and is 54 years old . Under his tenure as CRO, BankUnited highlighted improving profitability in 2024: net income of $232.5 million ($3.08 diluted EPS), ROAE of 8.5%, and ROAA of 0.66% for FY 2024, with quarterly trends in EPS, NIM, ROAA and ROAE improving through the year .

Past Roles

OrganizationRoleYearsStrategic impact
BankUnited, N.A.Chief Risk OfficerSep 2019–presentLed ERM consolidation; oversight of risk culture, regulatory relations, ACL oversight, asset quality maintenance .
BankUnited, N.A.Chief Credit OfficerJan 2018–Sep 2019Credit risk leadership prior to ERM consolidation .
TD Bank (and predecessors)Senior leadership roles2008–2018Experience across capital markets, C&I, CRE, consumer, specialty banking; M&A diligence/integration .
Compass BankSenior leadership role2006–2008Credit/risk and banking leadership .
Regions Bank (and predecessors)Senior leadership roles1999–2006Credit/risk leadership across business lines .
Bank One (JPMorgan Chase)Early career roles1993–1999Foundational experience across banking and workout/recovery .

External Roles

OrganizationRoleYearsNotes
No external directorships or public company board roles disclosed in Mr. Richards’ biography in the proxy .

Fixed Compensation

YearBase salary ($)All other compensation ($)Notes
2024425,000 15,525 (401(k) contribution) No 2024 base salary changes for NEOs; CRO listed at $425k .
2023420,833 14,850
2022400,000 13,725
  • Deferred comp: Mr. Richards does not participate in the Nonqualified Deferred Compensation Plan .
  • Pension/SERP: Company has no defined benefit pension plans .
  • Perquisites: None disclosed for Richards beyond standard benefits; no excise tax gross-ups company-wide .

Performance Compensation

Annual incentive (cash)

Performance yearAward ($)StructureKey evaluation criteriaApproval date
2024400,000 Discretionary under Company’s Policy on Incentive Compensation Arrangements (separate from NEO AIP to preserve CRO independence) Risk culture program, enterprise-wide RCSA framework, enhancements to risk assessment, regulatory relations, portfolio concentrations/performance reporting, acceptable asset quality, ACL oversight/challenge Feb 19, 2025
2023350,000 Discretionary per policy Executing ERM/Credit governance; sound frameworks; rating system; balanced risk culture Feb 21, 2024
2022375,000 Discretionary per policyCompany policy-driven evaluation of contributions and responsibilities
  • Unlike other NEOs, Richards does not participate in the formulaic AIP tied 75% to financial metrics and 25% to strategic objectives, to avoid misaligned incentives for the CRO .

Equity awards (restricted shares)

Grant dateTypeShares (#)Grant-date fair value ($)Vesting schedule
Mar 1, 2025Restricted shares (RSA)13,500 — (to be reported in 2026 proxy) 25% on each of Mar 1, 2026/2027/2028/2029, subject to service .
Mar 1, 2024Restricted shares (RSA)13,000 340,990 Equal annual installments on Mar 1, 2025/2026/2027/2028, subject to service; participates in dividends .
HistoricalRestricted shares (RSA)Included in outstanding totalsSee “Vesting schedule” below .

Vesting and realized shares:

  • 2024 vesting: 12,250 restricted shares vested; value realized $321,318 .
  • Outstanding at Dec 31, 2024: 31,750 unvested RSAs (12,500 vested on Mar 1, 2025; 9,500 vest Mar 1, 2026; 6,500 on Mar 1, 2027; 3,250 on Mar 1, 2028) .

Equity Ownership & Alignment

As ofBeneficial ownership (shares)% of shares outstandingNotes
Mar 25, 202543,135 ~0.06% (43,135 / 75,242,048) Footnote indicates restricted shares included; anti-pledging/hedging policy applies .
Mar 18, 202447,330 Includes restricted shares; change vs 2025 likely reflects net share settlement on vesting .

Stock ownership guidelines and compliance:

  • Requirement: 3x base salary for NEOs; Richards required to hold ~$1,275,000 and is in compliance (based on policy ratification and $28.00 stock price as of Mar 28, 2024) ; reaffirmed as “Yes” in Feb 2025 policy ratification .
  • Anti-hedging/anti-pledging: Executives are prohibited from pledging company securities or engaging in hedging transactions; no margin accounts .
  • Clawback: Company maintains an NYSE/SEC-compliant compensation recovery policy for restatements; excess incentive-based comp must be recouped .

Near-term vesting/selling pressure:

  • Upcoming vest tranches: 9,500 shares (Mar 1, 2026), 6,500 (Mar 1, 2027), 3,250 (Mar 1, 2028) from 2024 grant, plus 3,375 per year from the 2025 grant (Mar 1, 2026–2029) subject to service .
  • Company’s executive ownership policy restricts sales if holdings would fall below guideline thresholds .

Employment Terms

Severance and change-in-control (CIC) economics (current policy basis, 2024 year-end assumptions):

ScenarioCash severanceContinued benefitsEquity accelerationNotes/Trigger
Termination without cause / for good reason (following CIC)1,211,898 Double-trigger equity acceleration within 24 months post-CIC; assumed cash-out valuation at $38.17 .
Change in control (no termination)Equity awards assumed/continued; no single-trigger vesting (other than CEO program) .
  • Company-wide equity treatment: If awards are assumed at CIC, no acceleration at closing; acceleration occurs only upon qualifying termination within 24 months (double-trigger) .
  • Historical note (at hire): Richards had a CIC agreement (commenced Jan 29, 2018) that paid lump sums equal to 3x/2x/1x base salary if CIC occurred within first three years of employment; subsequent proxies reflect current limited severance framework with no cash multiple for Richards .
  • Clawback and insider trading controls as noted above .

Performance & Track Record

  • 2024 contribution highlights used in evaluation and award: developed risk awareness culture, implemented enterprise-wide RCSA, enhanced risk assessment framework, maintained strong regulatory relationships, monitored portfolio concentrations/performance, maintained acceptable asset quality, and provided ACL oversight/effective challenge .
  • Company performance context: In 2024, EPS, NIM, ROAA, ROAE improved sequentially; funding mix improved (NIDDA 27.3%; wholesale funding ratio 23.4%), while relative NPA metric did not pay out for other NEOs’ AIP program; CRO remained on separate discretionary program to preserve independence .

Company Financial Context (tenure backdrop)

MetricFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024
Revenues ($)147,204,000*133,221,000*134,153,000*77,636,000*86,838,000*99,155,000*

Values retrieved from S&P Global.

Compensation Structure Analysis (signals)

  • Mix and risk: CRO does not participate in formulaic AIP or PSUs; cash incentive is discretionary under a risk-balanced policy, reducing potential for risk-taking tied to earnings metrics; equity awards are time-based RSAs with 4-year ratable vesting, aligning retention and long-term orientation .
  • Governance alignment: No excise tax gross-ups; anti-hedging/anti-pledging; robust clawback; executive stock ownership policy with compliance confirmed for Richards .
  • CIC design: Double-trigger equity acceleration only; no ongoing cash severance multiple for Richards in the current framework, limiting windfall risk .
  • Say-on-pay signal: 78% support in 2024 (below prior 3-year average of 99%); committee enhanced disclosures; context cited that 2023 TSR headwinds impacted vote .

Investment Implications

  • Alignment: Time-based RSAs with multi-year vesting and strict anti-pledging/ownership rules support alignment; absence of formulaic pay tied to EPS/NIM for the CRO reduces incentives for pro-cyclical risk-taking .
  • Retention risk: Four-year vesting cadence (2026–2029) and regular RSA grants support retention; lack of cash severance multiple reduces parachute value and could increase external poaching risk in a tight CRO talent market .
  • Trading/overhang: Known vesting tranches (9.5k in 2026; 6.5k in 2027; 3.25k in 2028; plus 3.375k annually 2026–2029 from new grant) create predictable potential supply; mitigated by ownership policy restricting sales below guideline levels .
  • Execution: 2024 performance gains in profitability and funding mix occurred alongside CRO’s risk oversight and asset quality focus, a constructive signal for continued disciplined growth .

Citations

  • Executive biography, age, education, roles:
  • Company 2024 performance metrics:
  • Base salary table and no changes:
  • Summary Compensation Table (2022–2024):
  • CRO incentive structure and 2024 criteria/award:
  • 2024 Grants of Plan-Based Awards (13,000 RSAs):
  • RSA vesting terms and outstanding awards (31,750 at FY-end; schedule):
  • 2024 vested shares/value:
  • 2025 CRO RSA grant (13,500; vest 2026–2029):
  • Beneficial ownership (2025/2024): ; record-date shares outstanding:
  • Ownership policy, compliance; anti-hedging/pledging; clawback:
  • CIC treatment and potential payments table:
  • Historical Richards CIC agreement (2018 hire window):
  • No defined benefit plans:
  • Deferred comp non-participation:
  • Say-on-pay/engagement: